Pfizer, Moderna have delivered 'best news so far' in COVID-19 fight, but USA TODAY's vaccine panel warns of logistical challenges
Published
Expert panel pushes USA TODAY's COVID vaccine clock ahead on positive candidate news but logistic challenges loom getting doses into American's arms.